Royal Bank Of Canada Issues Positive Forecast for Amrize (NYSE:AMRZ) Stock Price

Amrize (NYSE:AMRZ) had its price objective raised by analysts at Royal Bank Of Canada from $60.00 to $61.00 in a report issued on Thursday,Benzinga reports. The firm currently has a “sector perform” rating on the stock. Royal Bank Of Canada’s target price would indicate a potential downside of 3.74% from the company’s previous close.

Other research analysts also recently issued research reports about the company. Deutsche Bank Aktiengesellschaft set a $59.00 target price on Amrize in a report on Monday, December 8th. UBS Group lifted their price objective on shares of Amrize from $53.00 to $57.00 and gave the company a “neutral” rating in a research report on Thursday, January 8th. Sanford C. Bernstein reaffirmed an “outperform” rating and set a $70.00 target price on shares of Amrize in a research note on Thursday, December 18th. Vertical Research assumed coverage on shares of Amrize in a research note on Tuesday, November 25th. They issued a “hold” rating and a $54.00 price target on the stock. Finally, Wall Street Zen upgraded Amrize to a “hold” rating in a report on Saturday, October 25th. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and six have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, Amrize has an average rating of “Moderate Buy” and a consensus target price of $62.54.

Amrize Trading Down 0.5%

Amrize stock traded down $0.33 during trading hours on Thursday, reaching $63.37. The company had a trading volume of 1,386,032 shares, compared to its average volume of 3,465,120. The company has a debt-to-equity ratio of 0.38, a current ratio of 1.45 and a quick ratio of 0.97. Amrize has a 12-month low of $44.12 and a 12-month high of $64.83. The firm has a market cap of $35.05 billion and a price-to-earnings ratio of 34.44. The company has a 50-day moving average price of $55.76 and a 200 day moving average price of $52.30.

Amrize (NYSE:AMRZ) last announced its earnings results on Tuesday, February 17th. The company reported $0.62 earnings per share for the quarter, beating analysts’ consensus estimates of $0.59 by $0.03. The business had revenue of $2.84 billion for the quarter, compared to the consensus estimate of $2.95 billion. The firm’s revenue for the quarter was down .4% compared to the same quarter last year.

Institutional Trading of Amrize

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Vanguard Group Inc. boosted its holdings in shares of Amrize by 5.6% in the 4th quarter. Vanguard Group Inc. now owns 31,770,926 shares of the company’s stock worth $1,722,500,000 after buying an additional 1,676,843 shares during the last quarter. Norges Bank purchased a new stake in shares of Amrize in the fourth quarter valued at approximately $929,333,000. Dodge & Cox purchased a new stake in shares of Amrize during the 2nd quarter valued at $622,085,000. Wellington Management Group LLP grew its stake in Amrize by 48.8% in the 3rd quarter. Wellington Management Group LLP now owns 11,622,024 shares of the company’s stock valued at $561,018,000 after acquiring an additional 3,809,133 shares during the period. Finally, Harris Associates L P purchased a new stake in shares of Amrize in the 4th quarter valued at $615,406,000.

Key Stories Impacting Amrize

Here are the key news stories impacting Amrize this week:

• Positive Sentiment: Management proposed a sizable shareholder-return package — a $1.0 billion buyback authorization plus a one-time special dividend and a proposed annual dividend — which supports near-term EPS accretion and signals confidence in cash generation. Quiver Quant: Amrize jumps 11% on Q4 results
• Positive Sentiment: Strong cash flow and lower leverage: 2025 operating cash flow and free cash flow were robust and year‑end net leverage fell to ~1.1x, giving the company capacity to fund buybacks/dividends while maintaining investment flexibility. Quiver Quant: Cash flow and leverage detail
• Positive Sentiment: Upbeat 2026 outlook: management guided to mid-single-digit revenue growth and stronger adjusted‑EBITDA growth (roughly +8%–11%), which frames 2026 as a margin/cash-flow improvement year. Yahoo Finance: Q4 Earnings Call Highlights
• Positive Sentiment: Strategic M&A: Amrize closed the acquisition of PB Materials, adding 26 operational sites and West Texas aggregates reserves — expands North American scale and long‑term supply capacity in a high-growth market. Business Wire: Amrize closes PB Materials acquisition
• Neutral Sentiment: Form 10‑K filed showing full‑year 2025 revenue of $11.8B and adjusted EBITDA ~ $3.0B — useful baseline data for investors but largely confirmatory. TipRanks: Form 10-K filing
• Neutral Sentiment: Q4 results were mixed: EPS beat modestly ($0.62 vs $0.59 est.) but revenue missed (about $2.84B vs $2.95B est.) and revenue was roughly flat year‑over‑year — beats on EPS and margin commentary offset by softer top-line. Yahoo Finance: Earnings Call Transcript
• Neutral Sentiment: Unusual options activity: a surge in call buying signals short‑term bullish positioning by traders, which can amplify intraday moves but is not fundamental by itself.
• Negative Sentiment: Some sell‑side caution: Jefferies issued a Hold, reflecting that while returns and cash flow are attractive, valuation/near‑term growth execution may not justify a buy rating for all investors. Globe and Mail: Jefferies Hold

Amrize Company Profile

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.